|
CAS No. | 193153-04-7 |
Chemical Name: | Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate |
Synonyms: | FXV 673;Preluent;FXV673/FXV-673;OtaMixaban (FXV 673);Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate;Methyl (2R,3R)-2-{3-[aMino(iMino)Methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]aMino}butanoate;(αR)-3-(AMinoiMinoMethyl)-α-[(1R)-1-[[4-(1-oxido-4-pyridinyl)benzoyl]aMino]ethyl]benzenepropanoic Acid Methyl Ester;[R-(R*,R*)]-3-(AMinoiMinoMethyl)-α-[1-[[4-(1-oxido-4-pyridinyl)benzoyl]aMino]ethyl]benzenepropanoic Acid Methyl Ester |
CBNumber: | CB62510035 |
Molecular Formula: | C25H26N4O4 |
Formula Weight: | 447.50628 |
MOL File: | 193153-04-7.mol |
|
|
|
|
Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate Property |
|
Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate Chemical Properties,Usage,Production |
Usage
A potent (Ki = 0.5 nM), selective, rapid acting, competitive and reversible fXa inhibitor that effectively inhibits both free and prothrombinase-bound fXa. Clinical studies show that it is efficacious
, safe and well tolerated in humans and therefore has considerable potential for the treatment of acute coronary syndrome. |
|
|
Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate Preparation Products And Raw materials |
Raw materials
|
Preparation Products
|
Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate Suppliers Global( 18)Suppliers |
|
|
|
|